Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
about
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic reviewMetabolism of ciclesonide in the upper and lower airways: review of available data.Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma.Ciclesonide for the treatment of asthma.Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.Ciclesonide in persistent asthma: the evidence of its therapeutic value.In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma.Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer.Management of asthma in adultsCiclesonide and the treatment of asthma.Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma.From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids.Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma.Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis.Inhalational Ciclesonide found beneficial in prevention of fat embolism syndrome and improvement of hypoxia in isolated skeletal trauma victims.Overview of novel therapeutic targets for asthma and chronic obstructive pulmonary disease.
P2860
Q33245730-41C07562-E151-4538-B3DD-765A6A1E3FF0Q33855461-666DE8C4-C45C-4A88-A232-2A4A81ACE8B8Q34623848-5164C580-C82A-4BDA-9A34-43BDEDEB18EAQ35166788-086875E9-FBF8-4B6B-8260-A94685B10891Q35225926-1F53D566-C93F-4A5D-9473-4B5D593F7C00Q35876418-D63303CE-F44E-40CD-BE31-0F5C627D970FQ36128735-1273A974-1353-4C01-88A6-ABB282CDE785Q36455870-424D1AA3-F5EC-4602-A37D-2BE2A6CD11D6Q36613943-C59113C5-12F3-48D0-BEA3-EA58B3D6C2E0Q36782563-85AF4D91-6276-4719-87BE-EA79CB80D709Q36885103-E9FF81BE-70C7-445C-A32D-A65C11B8905FQ37460865-6541755C-1141-4F10-B5DA-10E90364EEFFQ37681579-2AD6B85D-6E10-4180-9F3D-EF1366B6662CQ38064899-949D91F2-958C-437B-B585-9A8894459798Q38091676-A0D14A2F-8D50-4204-BD1A-B00276855788Q38130512-F0A01084-D508-4120-A6B0-7DDF66FB2829Q42854436-7C74B42D-FC1C-46FE-AEAB-AECEDC388FEAQ43408225-01518470-1B43-48B4-A6B8-7FB246B3831EQ47601906-FC1B9AC9-5757-458C-BBA4-1078DBD8BB92Q47772639-E1203C17-8D62-4D4B-A6FF-BEB930067A40
P2860
Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Lower oropharyngeal deposition ...... e inhaler in healthy subjects.
@en
Lower oropharyngeal deposition ...... e inhaler in healthy subjects.
@nl
type
label
Lower oropharyngeal deposition ...... e inhaler in healthy subjects.
@en
Lower oropharyngeal deposition ...... e inhaler in healthy subjects.
@nl
prefLabel
Lower oropharyngeal deposition ...... e inhaler in healthy subjects.
@en
Lower oropharyngeal deposition ...... e inhaler in healthy subjects.
@nl
P2093
P1476
Lower oropharyngeal deposition ...... e inhaler in healthy subjects.
@en
P2093
Ruediger Nave
Thomas D Bethke
P2888
P304
P356
10.1007/S00228-005-0910-0
P577
2005-04-12T00:00:00Z